Xyntha recombinant Factor VIII regulatory update

FDA approved an sBLA from Pfizer for a prefilled, dual-chamber syringe formulation of Xyntha recombinant Factor VIII to control and prevent bleeding episodes and for surgical prophylaxis in patients w...